SCOR holds its course: combining growth, profitability and solvency to record a net result of EUR 330 million in 2011.

SCOR holds its course: combining growth, profitability and solvency to record a net result of EUR 330 million in 2011.

SCOR informe que son Document de référence 2011 a été déposé auprès de l’Autorité des marchés financiers (AMF) le 8 mars 2012.

Document PDF

The subject of this note is to propose a set of analytical methods to derive a “closed-form solution” for MVM for a Non-Life insurance company, from a theoretical model first, and then to fit this model to a given set

Le don de rein se développe partout dans le monde, certains pays à la pointe dans ce domaine, comme les Etats-Unis et le Japon, pays d’origine des études que nous avons exploitées pour cette publication.

SCOR réussit les renouvellements du 1er janvier 2012 : croissance de 13,9 %, conditions tarifaires satisfaisantes (+2 %) et rentabilité technique attendue

SCOR successfully concludes the January 1, 2012 renewals: 13.9% growth, satisfactory pricing conditions (+2%) and expected technical profitability.

SCOR Global P&C has recorded a very satisfactory increase in its business in 2011: gross written premiums are up by 8.8% to EUR 3.982 billion at current exchange rates.

SCOR Global P&C has recorded a very satisfactory increase in its business in 2011: gross written premiums are up by 8.8% to EUR 3.982 billion at current exchange rates.

The Continuous Mortality Investigation (CMI) has recently published Working Papers 52 and 58. These Papers represent a third phase in the activity of the CMI Critical Illness Committee.